Subscribe to Search results

Inquiry publishes timetable and opens registration for hearings in June

Published on:

Inquiry publishes timetable and opens registration for Treloar’s hearings

Published on:

Government announcement on expenses for legal representation

Published on:

Letter of Instruction to Public Health and Administration Group

Published on:

Inquiry Chair sets out plans for hearings in 2022

Published on:

Further instruction letter to Hepatitis expert group published

Published on:

Compensation Framework Study online

Published on:

Further information on submissions

Published on:

Public hearings factsheet - Cardiff (23-26 July)

Published on:

Timetable for public hearings 23-26 July 2019 (Cardiff)

Published on:

Update on January hearings 

Published on:

Update on February hearings and indicative timetable for 2022

Published on:

Update on Sir Robert Francis compensation framework study

Published on:

Alec Macpherson (Headmaster, Treloars) told the school about the two different types of hepatitis, information which came from the doctors at Treloars.

Published on:

A nursing sister raised concerns to Alec Macpherson about hepatitis at the Lord Mayor Treloar College around 1975.

Published on:

Dr Rosemary Biggs observed that "the collection of 49 haemophilic patients at the Alton School makes this a unique opportunity to study the disease."

Published on:

A report of a study at the Lord Mayor Treloar College stated that the "concentration in one residential centre of patients needing repeated transfusions has provided a good opportunity to study the incidence of Australia antigen and antibody in a vulnerable group".

Published on:

Pupils at Treloar's were identified as potential research subjects.

Published on:

Records indicated there were four completed research studies at Treloar's, a prophylactic treatment study nearing completion and two further research projects planned.

Published on:

Dr Peter Kirk's hepatitis study found "all cases of clinical hepatitis and most cases of asymptomatic hepatitis are confined to recipients of commercial concentrates".

Published on: